Early 3+3 trial dose-escalation phase I clinical trial design and suitability for immune checkpoint inhibitors
| Image |  |
|---|---|
| Description | scientific article published on 20 October 2020 |
| Author/s |
author: Pooja Mehra Anita Giobbie-Hurder |
| Publication date | October 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |